Ziprasidone Hydrochloride

DRUG5 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc., University Hospital Freiburg, Queen's University, Dr. Reddy's Laboratories Limited

Conditions

Acute ManiaBipolar Disorder, ManicConduct DisorderDepression, BipolarHealthyOppositional Defiant Disorder

Phase 1

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

CompletedNCT01581866

Dr. Reddy's Laboratories LimitedHealthy

Start: 2004-11-30End: 2005-01-31Updated: 2012-04-20

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions

CompletedNCT01581879

Dr. Reddy's Laboratories LimitedHealthy

Start: 2004-11-30End: 2005-01-31Updated: 2012-04-20

Phase 2

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

CompletedNCT00676429

University Hospital FreiburgConduct Disorder, Oppositional Defiant Disorder

Start: 2006-07-31End: 2008-06-30Updated: 2008-11-18

Phase 4

Ziprasidone And Olanzapine's Outcomes In Mania

TerminatedNCT00329108

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Acute Mania, Bipolar Disorder, Manic

Start: 2006-11-30End: 2008-01-31Updated: 2021-03-29

An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression

CompletedNCT00835107

Queen's UniversityDepression, Bipolar

Start: 2009-02-28End: 2011-06-30Updated: 2015-12-16